These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 36916128)
1. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide. Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128 [TBL] [Abstract][Full Text] [Related]
2. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562 [No Abstract] [Full Text] [Related]
3. Formulation of Metoclopramide Hydrochloride-Loaded Lipid Carriers by QbD Approach for Combating Nausea: Safety and Bioavailability Evaluation in New Zealand Rabbit. Baranauskaite J; Aydin M; Uner B; Tas C AAPS PharmSciTech; 2024 Apr; 25(4):73. PubMed ID: 38575825 [TBL] [Abstract][Full Text] [Related]
4. P-gp inhibition and enhanced oral bioavailability of amikacin Sulfate: A novel approach using Thiolated Chito-PEGylated Lipidic Hybrids. El-Say KM; Megahed MA; Abdalla A; El-Sawy HS; Afify H; Ramadan AA; Ahmed TA Int J Pharm; 2024 Jun; 658():124200. PubMed ID: 38710298 [TBL] [Abstract][Full Text] [Related]
5. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery. Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability. Uppuluri CT; Ravi PR; Dalvi AV Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852 [TBL] [Abstract][Full Text] [Related]
7. Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies. Gadhave D; Khot S; Tupe S; Shinde M; Tagalpallewar A; Gorain B; Kokare C Int J Pharm; 2022 Dec; 629():122372. PubMed ID: 36351503 [TBL] [Abstract][Full Text] [Related]
8. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats. Khan S; Patil K; Yeole P; Gaikwad R J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007 [TBL] [Abstract][Full Text] [Related]
9. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine. Hard SAAA; Shivakumar HN; Redhwan MAM Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522 [TBL] [Abstract][Full Text] [Related]
10. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment. Ahmad S; Khan I; Pandit J; Emad NA; Bano S; Dar KI; Rizvi MMA; Ansari MD; Aqil M; Sultana Y Int J Biol Macromol; 2022 Nov; 221():435-445. PubMed ID: 36067850 [TBL] [Abstract][Full Text] [Related]
11. Oleic acid-reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: A mechanistic ex-vivo/in-vivo analysis. El-Say KM; Ahmed TA; Aljefri AH; El-Sawy HS; Fassihi R; Abou-Gharbia M Int J Pharm; 2021 Oct; 608():121057. PubMed ID: 34461173 [TBL] [Abstract][Full Text] [Related]
12. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
13. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment. Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655 [TBL] [Abstract][Full Text] [Related]
14. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies. Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051 [TBL] [Abstract][Full Text] [Related]
15. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease. Uppuluri CT; Ravi PR; Dalvi AV Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426 [TBL] [Abstract][Full Text] [Related]
16. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. Khan S; Patil K; Bobade N; Yeole P; Gaikwad R J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503 [TBL] [Abstract][Full Text] [Related]
17. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Fatouh AM; Elshafeey AH; Abdelbary A Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900 [TBL] [Abstract][Full Text] [Related]
18. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation. Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977 [TBL] [Abstract][Full Text] [Related]
19. AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin. Sintov AC Int J Pharm; 2020 Oct; 588():119725. PubMed ID: 32763387 [TBL] [Abstract][Full Text] [Related]
20. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]